Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001158358
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/09/2026
Date registered
Help: Date registered
17/09/2026
Date last updated
Help: Date last updated
23/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/09/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Impact of Successful Ageing education on promoting health literacy in Western Australia: Waitlist Randomised Controlled Trial
Scientific title
Impact of Successful Ageing education on promoting health literacy in Western Australia: Waitlist Randomised Controlled Trial
Additional trial identifiers [1] 318373 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records
ACTRN12626000371392
This was the feasibility study of the Successful Ageing MOOC which has completed recruitment and data collection.

Health condition
Health condition(s) studied:
Health literacy 343511 0
Ageism 343512 0
Condition category
Condition code
Public Health 339614 339614 0 0
Health promotion/education

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Completion of the 'Successful Ageing' Massive Open Online Course (MOOC). This MOOC is an 8 module online resource co-designed which included consumers (65+ years), health professionals, allied health students and policy makers. The modules were initially developed based on prior successful ageing research and goal setting for older adults (DOI: 10.1093/geront/gnae102; DOI: 10.1186/s12877-024-05017-x) and then feedback (both written and verbal over Teams) was provided by the consumer cohort above at a time that suited each consumer. As the modules evolved the consumers were privy to the changes and given further opportunity to provide feedback. The MOOC has been developed by the Curtin EdX team.
The MOOC includes 8 modules:
1. Social connection
2. Mental wellbeing
3. Physical wellbeing
4. Physical health
5. Cognition
6. Financial stability
7. Independence
8. Enjoyment/Positivity
Each module includes text, videos and online material on each topic, and a short optional quiz at the end. Each module takes no longer than an hour and will be available for up to 8 weeks. All 8 modules are available as soon as the participant can access the MOOC. The modules are completed in order and the participant moves to the next once the former is completed. A feasibility study has recently been completed September 2026 and the results are being analysed (ACTRN12626000371392).
The MOOC is delivered online and participants can log in anytime/anywhere to access it once they have enrolled in the study. They will have access to the MOOC for 8 weeks.
Intervention code [1] 335266 0
Lifestyle
Description of the comparator or control
This will be a wait-list randomised controlled trial. After a participant consents to participate in the study through an online consent form, they will complete the demographic survey and then the Health literacy tool (Health Literacy Questionnaire (HLQ) tool) and the Expectations Regarding Aging Survey-12. After completing this they will be randomised to either the intervention or the wait-list group. The intervention group will have immediate access to the Successful Ageing MOOC, the wait-list group will do nothing for 8 weeks then be given access to the Successful Ageing MOOC to complete.
The MOOC is an online educational tool, no humans are delivering it. Both groups will be given 8 weeks to complete the 8 one-hour modules (they can complete them faster than 8 weeks). Each group will be given a reminder email at 4-weeks (i.e. half-way through) and also at 7-weeks (i.e. they will have one week left to complete the MOOC).
Control group
Active

Outcomes
Primary outcome [1] 346793 0
Health literacy
Timepoint [1] 346793 0
Baseline (T1), 8 weeks (T2), 16 weeks (T3), 24 weeks (T4)
Secondary outcome [1] 467532 0
Ageism
Timepoint [1] 467532 0
Baseline (T1), 8 weeks (T2), 16 weeks (T3), 24 weeks (T4)

Eligibility
Key inclusion criteria
Adults over 18 years of age with computer/internet access; we will aim to have 50% of participants being allied health students.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
Under 18 years of age
No computer and internet access

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
This is a wait-list RCT, both groups will be given the intervention, the wait-list group will be given access 8-weeks after the intervention group.
Randomisation will be concealed, computer-generated sequence of randomly permuted blocks (block size=6) in a 1:1 ratio and will be generated by a researcher not involved in the study. Randomisation will occur using REDCap after baseline data collection is completed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated sequence of randomly permuted blocks (block size=6) in a 1:1 ratio
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
Wait-list, where the wait-list group (delayed starters) start the intervention 8-weeks after the intervention (early starters)
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Using GPower 3.1.9.7 a sample size of 216 is required (108 per group), based on using the HLQ subscale (having sufficient information to manage my health) score (effect size 0.21) from a previous study, power of 80% and 5% significance across the three time measurement periods, allowing for 20% withdrawals.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
2/11/2026
Actual
Date of last participant enrolment
Anticipated
26/02/2027
Actual
Date of last data collection
Anticipated
27/08/2027
Actual
Sample size
Target
216
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 322936 0
Government body
Name [1] 322936 0
Healthway
Country [1] 322936 0
Australia
Primary sponsor type
University
Name
Curtin University
Address
Country
Australia
Secondary sponsor category [1] 325871 0
None
Name [1] 325871 0
Address [1] 325871 0
Country [1] 325871 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321361 0
Curtin University Human Research Ethics Committee
Ethics committee address [1] 321361 0
Ethics committee country [1] 321361 0
Australia
Date submitted for ethics approval [1] 321361 0
05/09/2024
Approval date [1] 321361 0
30/09/2024
Ethics approval number [1] 321361 0
HRE2024-0580-01

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153486 0
A/Prof Elissa Burton
Address 153486 0
Curtin School of Allied Health, Faculty of Health Sciences, Curtin University,, GPO Box U1987, Perth, Western Australia 6845.
Country 153486 0
Australia
Phone 153486 0
+61 8 9266 4926
Fax 153486 0
Email 153486 0
[email protected]
Contact person for public queries
Name 153487 0
Elissa Burton
Address 153487 0
Curtin School of Allied Health, Faculty of Health Sciences, Curtin University,, GPO Box U1987, Perth, Western Australia 6845.
Country 153487 0
Australia
Phone 153487 0
+61 8 9266 4926
Fax 153487 0
Email 153487 0
[email protected]
Contact person for scientific queries
Name 153488 0
Elissa Burton
Address 153488 0
Curtin School of Allied Health, Faculty of Health Sciences, Curtin University,, GPO Box U1987, Perth, Western Australia 6845.
Country 153488 0
Australia
Phone 153488 0
+61 8 9266 4926
Fax 153488 0
Email 153488 0
[email protected]

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
What individual participant data might be shared?
• De-identified individual participant data:
• Primary outcome(s)
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies testing whether findings can be repeated or confirmed
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
A finite period of: 3 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Requests can be made to the lead researcher [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Statistical analysis planNo Statistical Analaysis Plan for RCT waitlist study.pdf

Documents added automatically
No additional documents have been identified.